Triptans May Be Offered to Well-Informed Pregnant Women With Migraines

https://pubmed.ncbi.nlm.nih.gov/40719668/ An AHRQ-funded study found that using triptans—medications for migraine relief—during pregnancy did not lead to higher risks of birth complications. Researchers analyzed data from over two decades for more than 3,800 pregnant women with migraines and found no major differences in outcomes like preterm birth, cesarean delivery, or birth defects between those who used triptans and those who did not. Importantly, the triptan group reported no cases of miscarriage, ectopic pregnancy, or hypertensive disorders like preeclampsia. These results suggest that triptans, especially sumatriptan, may be a safe option for pregnant women who need medication to manage severe migraines. Access the abstract in Mayo Clinic Proceedings.